Bouguenais, France

Nathalie Dehorter

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: B&a Therapeutics, Centre Hospitalier Universitaire De Nantes, National Institute of Health and Medical Research. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nathalie Dehorter. Retrieved from https://idiyas.com/inventor/nathalie-dehorter

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nathalie Dehorter: Innovator in Neurodegenerative Disease Treatment

Introduction

Nathalie Dehorter is a prominent inventor based in Bouguenais, France. She has made significant contributions to the field of neurodegenerative diseases, particularly in the treatment of Parkinsonian syndromes. Her innovative work has led to the development of a unique composition aimed at improving the lives of those affected by these debilitating conditions.

Latest Patents

Nathalie holds a patent for "Modulators of intracellular chloride concentration for treating neurodegenerative diseases with Parkinsonian Syndromes." This composition is designed to treat neurodegenerative diseases in subjects in need, utilizing an effective amount of a modulator of a chloride transporter. This patent highlights her commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout her career, Nathalie has worked with notable institutions, including the Centre Hospitalier Universitaire De Nantes and B&A Therapeutics. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Nathalie has collaborated with esteemed colleagues such as Yehezkel Ben-Ari and Philippe Damier. These partnerships have enriched her research and expanded the impact of her work in the medical community.

Conclusion

Nathalie Dehorter is a trailblazer in the field of neurodegenerative disease treatment, with a focus on Parkinsonian syndromes. Her innovative patent and collaborative efforts underscore her dedication to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…